-
1
المؤلفون: Nalan Ulufi, Haluk Alagol, Ronald Johnson, Bahadir M. Gulluoglu, Betül Bozkurt, Serdar Özbaş, Neslihan Cabioglu, Emin Yildirim, Erol Aksaz, Cavit Col, Cihangir Ozaslan, G Gurleyik, Ali Uzunkoy, Mustafa Dulger, Neset Koksal, Ergun Erdem, Vahit Ozmen, Ayhan Koyuncu, Zafer Canturk, Semra Salimoglu, Atilla Soran, Mahmut Muslumanoglu, Bülent Ünal, U Berberoglu, Aykut Soyder, Zafer Utkan, Umit Ugurlu, Turkkan Evrensel, Abdullah Igci, Efe Sezgin, Atakan Sezer, Hasan Karanlik, Can Atalay, Cihan Uras, Omer Cengiz
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., Evrensel, Türkkan, AAJ-1027-2021, Tıp Fakültesi, Hitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
مصطلحات موضوعية: 0301 basic medicine, Survival rate, Secondary, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biomarkers, Tumor/metabolism, Breast Neoplasms/pathology/surgery/*therapy, Carcinoma, Ductal, Breast/secondary/surgery/*therapy, Carcinoma, Lobular/secondary/surgery/*therapy, Combined Modality Therapy/*mortality, Female, Follow-Up Studies, Humans, Mastectomy/*mortality, Middle Aged, Neoplasm Invasiveness, Neoplasm Metastasis, Prognosis, Radiotherapy/*mortality, Receptor, ErbB-2/metabolism, Receptors, Estrogen/metabolism, Receptors, Survival, Receptor, ErbB-2, medicine.medical_treatment, Neoplasm invasiveness, Receptors, progesterone, Cancer staging, Receptors, estrogen, law.invention, Progesterone receptor, Metastasis, Cancer growth, 0302 clinical medicine, Breast cancer, Randomized controlled trial, Metastatic-disease, law, Phase 3 clinical trial, Pathology, Estrogen receptor, Overall survival, Relapse, Middle aged, Mastectomy, Improves, Systemic therapy, Lobular carcinoma, Hazard ratio, [Belirlenecek], Metastatic Breast Cancer, Combined modality therapy, Metaanalysis, Primary tumor, Multicenter study, Management, Clinical trial, Oncology, Antineoplastic agent, 030220 oncology & carcinogenesis, Surgical resection, Locoregional Treatment, Paget nipple disease, Human, Adult, medicine.medical_specialty, Randomization, Breast surgery, Neoplasm metastasis, Tumor invasion, Breast tumor, Breast Neoplasms, Follow-up studies, Major clinical study, Carcinoma, ductal, breast, Lymph node dissection, Article, Epidermal growth factor receptor 2, 03 medical and health sciences, Antineoplastic combined chemotherapy protocols, medicine, Tumor marker, Mortality, Multimodality cancer therapy, Cancer recurrence, Performance status, Surgical Resection, Radiotherapy, business.industry, Locoregional treatment, ERBB2 protein, human, Bone metastasis, Follow up, medicine.disease, Carcinoma, lobular, Surgery, 030104 developmental biology, Metabolism, Biomarkers, tumor, Hormone Receptors, Metastatic-Disease, Therapy, Comparative study, business, Axillary lymph node, Removal, Controlled study
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca450e9e0b48affe299e5f4256819986
http://hdl.handle.net/11452/29566 -
2
المؤلفون: Shen Feng, Cristina R. Ferrone, Bryan M. Clary, Timothy M. Pawlik, J. Wallis Marsh, Andrew X. Zhu, Jean-François Gigot, Omar Hyder, T. Clark Gamblin, Carlo Pulitano, Hugo Marques, Irinel Popescu, Andreas Paul, Eduardo Barroso, Sorin Alexandrescu, Gilles Mentha, Todd W. Bauer, Georgios C. Sotiropoulos, Luca Aldrighetti
المساهمون: Hyder, O, Marques, H, Pulitano, C, Marsh, Jw, Alexandrescu, S, Bauer, Tw, Gamblin, Tc, Sotiropoulos, Gc, Paul, A, Barroso, E, Clary, Bm, Aldrighetti, L, Ferrone, Cr, Zhu, Ax, Popescu, I, Gigot, Jf, Mentha, G, Feng, S, Pawlik, Tm
المصدر: JAMA Surgery, Vol. 149, No 5 (2014) pp. 432-8
مصطلحات موضوعية: Cross-Cultural Comparison, Male, medicine.medical_specialty, Asia, Cirrhosis, Hepatectomy/methods/mortality, medicine.medical_treatment, Combined Modality Therapy/mortality, Medizin, Postoperative Complications/mortality, Cholangiocarcinoma, Bile Ducts, Intrahepatic/surgery, Postoperative Complications, Recurrence, medicine, Hepatectomy, Humans, Survivors, Survival analysis, Intrahepatic Cholangiocarcinoma, Neoplasm Staging, Chemotherapy, ddc:617, business.industry, Incidence (epidemiology), Hazard ratio, Cholangiocarcinoma/drug therapy/mortality/surgery, Middle Aged, Nomogram, medicine.disease, Combined Modality Therapy, Survival Analysis, digestive system diseases, Survivors/statistics & numerical data, United States, Surgery, Europe, Nomograms, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Chemotherapy, Adjuvant, Bile Duct Neoplasms/drug therapy/mortality/surgery, Female, Radiology, business, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d77880fa9dcce3c5f9b6a68c4c4ba6
https://doi.org/10.1001/jamasurg.2013.5168